Executives/Denali Therapeutics CEO
Ryan J. Watts, CEO of Denali Therapeutics

Who is the CEO of Denali Therapeutics in 2026?

Ryan J. Watts is the Chief Executive Officer, President and Director of Denali Therapeutics. Ryan has held the CEO seat since August 2015.

Updated September 24, 2026
Time in seat
11 years
CEO since August 2015
Career span
22 years
First recorded role January 2004
Education
University of Utah
Bachelor's Degree, Biology
Summary
  • Ryan J. Watts rose through Denali Therapeutics: CEO from January 2015, before taking the CEO seat in August 2015.
  • Ryan J. Watts sat on the board of Genentech from January 2004 to January 2015.
  • The newest member of the leadership team is Peter Chin, in seat since March 2026.

Current company

Denali Therapeutics

Denali Therapeutics is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using our proprietary TransportVehicle™ platform.

Biotechnology ResearchHeadquartered in South San FranciscoFounded 2015Nasdaq: DNLI

Source: Denali Therapeutics on LinkedIn
View Denali Therapeutics headcount

Career and education

Ryan J. Watts has been CEO of Denali Therapeutics since August 2015.

Career

  1. Denali Therapeutics2015 to present
    • CEO
  2. Genentech2004 to 2015
    • Director

Sources: LinkedIn profile

Education

University of Utah, Bachelor's Degree, BiologyStanford University, Doctor of Philosophy (Ph.D.), Biological SciencesSource

Decision makers by function

30+ decision makers at Denali Therapeutics in Unify, vice president level and above. Choose a function to see who leads it.

Decision maker preview

Top decision makers at Denali Therapeutics

Vice president level and above, most senior first
Andrew RobertsonSenior Vice President, Global Regulatory Affairs and Quality · USA@denalitherapeutics.com
Benjamin ZuffiVice President, Information Technology · USA@denalitherapeutics.com
Naim NazefVice President of Oligonucleotide Chemistry · USA@denalitherapeutics.com
Leah FrautschyVice President, Clinical Manufacturing · USA@denalitherapeutics.com
See every decision maker at Denali Therapeutics

Unlock every decision maker at Denali Therapeutics

Get verified profiles, contact data, and live buying signals in Unify.

Leadership team at Denali Therapeutics

Ryan J. Watts leads a leadership team of 3 published executives. The most recent appointment is Peter Chin as Chief Medical Officer, Head of Development, in seat since March 2026.

Executive leadership

NameTitleIn seat since
Ryan J. WattsPresident, Chief Executive Officer and DirectorAugust 2015
Alexander O. SchuthChief Operating and Financial Officer, and SecretaryMay 2022
Peter ChinChief Medical Officer, Head of DevelopmentMarch 2026

Sources: Denali Therapeutics 2026 DEF 14A

Frequently asked questions

Who is the CEO of Denali Therapeutics?

Ryan J. Watts is the Chief Executive Officer, President and Director of Denali Therapeutics. Ryan has held the CEO seat since August 2015.

When did Ryan J. Watts become CEO of Denali Therapeutics?

Ryan J. Watts has been CEO of Denali Therapeutics since August 2015, according to LinkedIn profile.

How long has Ryan J. Watts been CEO of Denali Therapeutics?

Ryan J. Watts has been CEO of Denali Therapeutics for 11 years, since August 2015.

Who else leads Denali Therapeutics?

Alexander O. Schuth (Chief Operating and Financial Officer, and Secretary), Peter Chin (Chief Medical Officer, Head of Development). Source: Denali Therapeutics 2026 DEF 14A.

Reach Denali Therapeutics' decision makers

30+ leaders at vice president level and above, with verified work emails and phone numbers in Unify.

Methodology

The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.

Identity confirmed against Denali Therapeutics on LinkedIn. Last verified: September 24, 2026.